Literature DB >> 7367644

Management of intramedullary spinal cord tumors.

G Kopelson, R M Linggood, G M Kleinman, J Doucette, C C Wang.   

Abstract

From January 1962 to May 1979, 23 patients with biopsy-proved intramedullary spinal cord tumors were treated initially with total resection, subtotal resection, irradiation, or subtotal resection and irradiation. Local control was achieved in 1/2 patients after total resection, 1/3 after subtotal resection, 8/9 after subtotal resection and radiation therapy, and 5/8 after radiation therapy alone. The patients with ependymomas exhibited a radiation dose-response relationship; of eight patients followed five or more years postirradiation, local control was achieved in 2/3 with time dose fraction (TDF) less than 55, 2/3 with TDF 55-65, and 2/2 with TDF greater than 65. The actuarial 5- and 10-year survival rates were 58% and 23% for astrocytoma, and 100% and 73% for patients with ependymoma, respectively. Neurological deficits improved or became totally normal after initial irradiation. Patterns of failure, management of recurrences, and radiotherapeutic techniques and dose recommendations are discussed.

Entities:  

Mesh:

Year:  1980        PMID: 7367644     DOI: 10.1148/radiology.135.2.7367644

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  32 in total

Review 1.  Radiation therapy and the management of intramedullary spinal cord tumors.

Authors:  S R Isaacson
Journal:  J Neurooncol       Date:  2000-05       Impact factor: 4.130

2.  Dynamic contrast-enhanced magnetic resonance imaging of osseous spine metastasis before and 1 hour after high-dose image-guided radiation therapy.

Authors:  Eric Lis; Atin Saha; Kyung K Peck; Joan Zatcky; Michael J Zelefsky; Yoshiya Yamada; Andrei I Holodny; Mark H Bilsky; Sasan Karimi
Journal:  Neurosurg Focus       Date:  2017-01       Impact factor: 4.047

Review 3.  Prognostic factors in intramedullary astrocytomas: a literature review.

Authors:  Vladimír Benes; Pavel Barsa; Vladimír Benes; Petr Suchomel
Journal:  Eur Spine J       Date:  2009-06-28       Impact factor: 3.134

4.  Total removal of cervicothoracic intramedullary 160-mm-long spinal cord ependymoma: a rare case report.

Authors:  Alaattin Yurt; Mehmet Selçuki; Ali Rıza Ertürk; Ali Küpelioğlu; Yahya Turan; Muammer Atıcı
Journal:  BMJ Case Rep       Date:  2009-03-06

5.  Intramedullary Spinal Cord Tumors.

Authors:  Daniel C. Bowers; Bradley E. Weprin
Journal:  Curr Treat Options Neurol       Date:  2003-05       Impact factor: 3.598

6.  Spinal myxopapillary ependymoma outcomes in patients treated with surgery and radiotherapy at M.D. Anderson Cancer Center.

Authors:  Serap Akyurek; Eric L Chang; Tse-Kuan Yu; Darrin Little; Pamela K Allen; Ian McCutcheon; Anita Mahajan; Moshe H Maor; Shiao Y Woo
Journal:  J Neurooncol       Date:  2006-04-29       Impact factor: 4.130

7.  Case report 435: Myxopapillary ependymoma of filum terminale with massive bone destruction of sacrum.

Authors:  T Matsuno; K Kaneda; T Nojima
Journal:  Skeletal Radiol       Date:  1987       Impact factor: 2.199

8.  Outcome of children with primary intramedullary spinal cord tumors.

Authors:  H H Hardison; R J Packer; L B Rorke; L Schut; L N Sutton; D A Bruce
Journal:  Childs Nerv Syst       Date:  1987       Impact factor: 1.475

Review 9.  Ependymomas of the filum terminale in childhood: report of four cases and review of the literature.

Authors:  F M Gagliardi; L Cervoni; M Domenicucci; P Celli; M Salvati
Journal:  Childs Nerv Syst       Date:  1993-02       Impact factor: 1.475

10.  Spinal cord tumors: gadolinium-DTPA-enhanced MR imaging.

Authors:  M C Chamberlain; A D Sandy; G A Press
Journal:  Neuroradiology       Date:  1991       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.